Alembic Pharma Gets USFDA Closure for Vadodara Facility
Shares of Alembic Pharmaceuticals Ltd soared 3% on September 17 after the US Food and Drug Administration (USFDA) closed its inspection of the company’s bioequivalence...
Tag : Alembic Pharmaceuticals Ltd
Nifty Pharma Slides as Trump’s Proposed Generic Drug Tariffs
Pharmaceutical stocks witnessed sharp selling pressure on Wednesday after US President Donald Trump proposed a phased tariff structure on imported generic medicines, sparking concerns over...
Alembic Pharma Shares Gain 2% on USFDA Tentative Approval
Shares of Alembic Pharmaceuticals witnessed a positive move, gaining 2%, on 14 May after the company secured tentative approval from the US Food and Drug...
Alembic Pharma Gets USFDA Nod for Cancer Drug; Shares End Flat
Shares of Alembic Pharmaceuticals Ltd ended flat after touching a day’s high of Rs 804.15 on 12th January, even as the company said it had...
Alembic Pharma Shares Rally 4% on Securing Final USFDA Approval
Shares of Alembic Pharmaceuticals Ltd rallied 4% on Monday, 17 November, after the company announced securing final approval from the USFDA for its angina medication....
Alembic Pharma Shares Slump Despite USFDA Approval
Shares of Alembic Pharmaceuticals Ltd were trading in the red and 1% lower on 29 October despite the company announcing securing final approval from the...
Alembic Pharma Shares Trade 2% Higher on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd increased 2% on Tuesday, 19 August 2025, on securing a final approval from the USFDA. Alembic Pharmaceuticals gained final approval...
Alembic Pharma Shares Up 2% on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd rose more than 2% on Monday, 18 August, after the company announced that it had achieved final USFDA approval. In...
Alembic Pharma Shares Surge 2% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd surged more than 2% on 28 July after the company announced securing final approval from the USFDA for Carbamazepine Extended-Release...
Alembic Pharma Shares Surge 2% on Acquiring Utility Therapeutics
Shares of Alembic Pharmaceuticals Ltd surged 2% on 3 July after the company’s wholly-owned subsidiary, Alembic Pharmaceuticals Inc., purchased Utility Therapeutics Ltd. to broaden its...